BROWSE·page 8 of 602

Browse EX-10 agreements

7,218 matching material contract exhibits.


EXHIBIT 10.7

Bridgecrest Auto Funding LLC

Exhibit 10.7

** **


ASSET REPRESENTATIONS REVIEW AGREEMENT

Bridgecrest Lending Auto Securitization Trust 2026-4,
as Issuer,

Bridgecrest Lending Auto Securitization Grantor Trust 2026-4,
as Grantor Trust,

Bridgecrest Acceptance Corporation,
as Sponsor and Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,
as Asset Representations Reviewer

Dated as of October 22, 2026

Table of Contents

Page

…

EX-10.7·8-K·CIK 2151184·ACC 0001104659-26-115376·Filed Oct 13, 2026, 12:16 ET

COMBINED DEFINITIVE TENDER OFFER AGREEMENTS

Cavitation Technologies, Inc.

TENDER OFFER AGREEMENT

[Cavitation Technologies, Inc.]

** **

This TENDER OFFER AGREEMENT (“Agreement”), dated and made effective as of October 9, 2026 (“Effective Date”), is entered into by and between BRIGHTFLIXX FINANCE (LUXEMBOURG) S.A,, a public limited company (société anonyme) organized and existing under the laws of Luxembourg (“Purchaser”), and CAVITATION TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Nevada (USA) (“Company”). The parties hereto are sometimes referred to individually herein as a “Party” or and collectively as the “Parties”.

R E C I T A L S

** **

A.Purchaser has proposed to acquire all of the outstanding shares of common stock in Company (the “Shares”), a reporting company under Section 13 and Section 15(d) of the Securities Exchange Act of 1934 (“Exchange Act”), for a total amount or price of $35 million in cash, less its outstanding liabilities, yielding a price per Share (“Offer Price”) determined in accordance with the terms of this Agreement) (the “Offer”);

…

EX-10.1·8-K·CIK 1376793·ACC 0001683168-26-007778·Filed Oct 13, 2026, 09:42 ET

EX-10.3

Alaunos Therapeutics, Inc.

SHARE REPURCHASE AND VOTING AGREEMENT

This Share Repurchase and Voting Agreement (this “Agreement”) is entered into as of October 13, 2026, by and among Alaunos Therapeutics, Inc., a Delaware corporation (“Parent”), Water Mill Asset Management Corp., a New York corporation (“Water Mill”), Robert W. Postma (“Postma” and, together with Water Mill, the “Postma Holders”), Jaime W. Vieser (“Vieser”) and, solely for purposes of Section 4(d), Velaris Therapeutics, Inc., a Delaware corporation (“Velaris”). Each of (a) the Postma Holders, together, and (b) Vieser is a “Holder”; each of Water Mill, Postma and Vieser is a “Holder Party”; and Postma and Vieser are each the “Holder Director” of his respective Holder.

…

EX-10.3·8-K·CIK 1107421·ACC 0001193125-26-419829·Filed Oct 13, 2026, 09:28 ET

EX-10.1

Alaunos Therapeutics, Inc.

Confidential

Proposed Execution Version

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT(this “Agreement”) is dated as of October 13, 2026, by and among Alaunos Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the “Securities Act”);

…

EX-10.1·8-K·CIK 1107421·ACC 0001193125-26-419829·Filed Oct 13, 2026, 09:28 ET

EX-10.2

Alaunos Therapeutics, Inc.

Confidential

Proposed Execution Version

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT(this “Agreement”), dated as of October 14, 2026, is entered into by and among Alaunos Therapeutics, Inc., a Delaware corporation (“Alaunos”), the several investors signatory hereto and each Merger Holder that becomes a party hereto in accordance with Section 10(b) (individually as an “Investor” and collectively, together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among Alaunos and the Investors party thereto, dated on or around the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

…

EX-10.2·8-K·CIK 1107421·ACC 0001193125-26-419829·Filed Oct 13, 2026, 09:28 ET

** EXHIBIT 10.5**

ASSIGNMENT ASSUMPTION AND AMENDED & RESTATED WARRANT AGREEMENT

This ASSIGNMENT ASSUMPTION AND AMENDED & RESTATED WARRANT AGREEMENT (this “Agreement” or the “A&R Warrant Agreement”) is made as of [•] (the “Effective Date”) among Horizon Space Acquisition I Corp., a Cayman Islands exempted company limited by shares, with offices at 1412 Broadway, 21st Floor, Suite 21V, New York, NY 10018 (“SPAC”), ArcheNova Technology Co., Ltd, a Cayman Islands exempted company limited by shares (“PubCo”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, with offices at 1 State Street, New York, New York 10004, as warrant agent (“Warrant Agent”).

RECITALS

WHEREAS, SPAC and the Warrant Agent are parties to that certain Warrant Agreement, dated as of December 21, 2022 (the “Existing* Warrant Agreement*”);

…

EX-10.5·8-K·CIK 1946021·ACC 0001929980-26-000542·Filed Oct 13, 2026, 08:30 ET

FORM OF LOCK-UP AGREEMENT

Horizon Space Acquisition I Corp.

LOCK-UP AGREEMENT

This LOCK-UP AGREEMENT is made as of [•] (this “Agreement”) by and between ArcheNova Technology Co., Ltd, a Cayman Islands exempted company (“PubCo”), and each of the undersigned (each, a “Shareholder”). Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to such terms in the Business Combination Agreement (as defined below).

WHEREAS, on October 12, 2026, Horizon Space Acquisition I Corp., a Cayman Islands exempted company (“Acquiror” or “SPAC”), PubCo, ArcheNova International Co., Ltd, a Cayman Islands exempted company and a wholly-owned subsidiary of PubCo (“Merger Sub I”), ArcheNova Global Co., Ltd, a Cayman Islands exempted company and a wholly-owned subsidiary of PubCo (“Merger Sub II”), and ArcheNova Biotech Corp., a Cayman Islands exempted company (the “Company”), entered into a Business Combination Agreement (the “Business Combination Agreement”) pursuant to which, upon the terms and subject to the conditions set forth therein: (a) Merger Sub I will merge with and into Acquiror (the “*First Merger

…

EX-10.4·8-K·CIK 1946021·ACC 0001929980-26-000542·Filed Oct 13, 2026, 08:30 ET

SPONSOR PARTIES SUPPORT AGREEMENT

Horizon Space Acquisition I Corp.

***SPONSOR PARTIES SUPPORT AGREEMENT ***

This Sponsor Parties Support Agreement (this “Agreement”) is made and entered into as of October 12, 2026, by and among (i) ArcheNova Technology Co., Ltd, a Cayman Islands exempted company (“PubCo”), (ii) ArcheNova Biotech Corp., a Cayman Islands exempted company (the “Company”), (iii) Horizon Space Acquisition I Sponsor Corp., a Cayman Islands exempted company (the “Sponsor”), (iv) each of the directors and officers of Acquiror identified on Schedule A hereto (together with the Sponsor, the “Sponsor Parties” and each, a “Sponsor Party”), and (v) Horizon Space Acquisition I Corp., a Cayman Islands exempted company (“Acquiror”). PubCo, the Company, Acquiror and the Sponsor Parties are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

RECITALS

…

EX-10.2·8-K·CIK 1946021·ACC 0001929980-26-000542·Filed Oct 13, 2026, 08:30 ET

FORM OF REGISTRATION RIGHTS AGREEMENT

Horizon Space Acquisition I Corp.

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [•], is made and entered into by and among ArcheNova Technology Co., Ltd, a Cayman Islands exempted company limited by shares (“PubCo”), and each of the undersigned parties listed on the signature pages hereto under “Holders” (together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, each, a “Holder” and collectively, the “Holders”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

RECITALS

…

EX-10.3·8-K·CIK 1946021·ACC 0001929980-26-000542·Filed Oct 13, 2026, 08:30 ET

COMPANY SHAREHOLDERS SUPPORT AGREEMENT

Horizon Space Acquisition I Corp.

COMPANY SHAREHOLDERS SUPPORT AGREEMENT

This Company Shareholders Support Agreement (this “Agreement”) is made and entered into as of October 12, 2026, by and among (i) ArcheNova Technology Co., Ltd, a Cayman Islands exempted company (“PubCo”), (ii) ArcheNova Biotech Corp., a Cayman Islands exempted company (the “Company”), (iii) certain shareholders of the Company (each, a “Requisite Shareholder”), and (iv) Horizon Space Acquisition I Corp., a Cayman Islands exempted company (the “Acquiror”). PubCo, the Company, Acquiror, and the Requisite Shareholders are sometimes referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

RECITALS

…

EX-10.1·8-K·CIK 1946021·ACC 0001929980-26-000542·Filed Oct 13, 2026, 08:30 ET

EX-10.1 - ACCELEVATION CREDIT AGREEMENT

Accelevation Holdings Corp.

Published Deal CUSIP: 00463QAA0

Published Revolver CUSIP: 00463QAB8

Published Term Loan CUSIP: 00463QAC6

CREDIT AGREEMENT

dated as of October 9, 2026

among

ACCELEVATION HOLDINGS LLC,

as Holdings,

ACCELEVATION LLC,

as the Borrower,

the several Lenders from time to time parties hereto,

and

BANK OF AMERICA, N.A.,

as the Administrative Agent and the Collateral Agent,

JPMORGAN CHASE BANK, N.A.,

MORGAN STANLEY SENIOR FUNDING, INC.,

KEYBANK NATIONAL ASSOCIATION,

PNC CAPITAL MARKETS LLC

and

BARCLAYS BANK PLC,

as Co-Syndication Agents

BOFA SECURITIES, INC.,

JPMORGAN CHASE BANK, N.A.,

MORGAN STANLEY SENIOR FUNDING, INC.,

KEYBANK NATIONAL ASSOCIATION

and

PNC CAPITAL MARKETS LLC,

as Joint Lead Arrangers

BOFA SECURITIES, INC.

and

JPMORGAN CHASE BANK, N.A.,

as Joint Bookrunners

-i-

TABLE OF CONTENTS

…

EX-10.1·8-K·CIK 2141406·ACC 0001628280-26-065600·Filed Oct 13, 2026, 08:23 ET